LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis (2018)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.895
Publication URI: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.895
Type: Journal Article/Review
Parent Publication: Atherosclerosis